Belite Bio, Inc
BLTE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,880,157 | $2,124,602 | $1,984,684 |
| - Cash | – | $0 | $0 | $31,677 |
| + Debt | – | $0 | $0 | $537 |
| Enterprise Value | – | $1,880,157 | $2,124,602 | $1,953,544 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$21,690 | -$16,278 | -$15,475 | -$7,579 |
| % Margin | – | – | – | – |
| Net Income | -$21,690 | -$16,320 | -$14,277 | -$10,100 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.65 | -0.5 | -0.44 | -0.32 |
| % Growth | -30% | -13.6% | -37.5% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |